Mohammad Aghaei, Ardavan
Urban Spillane, Lia
Pittman, Brian
Flynn, L. Taylor
De Aquino, Joao P.
Bassir Nia, Anahita
Ranganathan, Mohini https://orcid.org/0000-0002-8412-2923
Funding for this research was provided by:
National Institute on Drug Abuse (1R21DA038821-01A1, K23DA052682, R21DA057240)
National Institute of Mental Health (K12 DA000167)
Article History
Received: 6 November 2023
Accepted: 23 May 2024
First Online: 4 June 2024
Declarations
:
: J.P.D. has been supported in clinical trials by Jazz Pharmaceuticals, specifically through medication provisions. Additionally, J.P.D. has been a compensated consultant for Boehringer Ingelheim. A.B.N is a member of the Scientific Advisory Committee of Synendos Therapeutics AG, Switzerland.